EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity

Christopher J Fritschi, Saumya Anang, Zhen Gong iD, Mohammadjavad Mohammadi iD, Jonathan Richard, Catherine Bourassa, Kenny T Severino, Hannah Richter, Derek Yang, Hung-Ching Chen, Ta-Jung Chiu, Michael S Seaman iD und 6 weitere

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2222073120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Christopher J Fritschi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: HIV-1, HIV Seropositivity, HIV Infections. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Binding to the host cell receptors, CD4 and CCR5/CXCR4, triggers large-scale conformational changes in the HIV-1 envelope glycoprotein (Env) trimer [(gp120/gp41) 3 ] that promote virus entry into the cell. CD4-mimetic compounds (CD4mcs) comprise small organic molecules that bind in the highly conserved CD4-binding site of gp120 and prematurely induce inactivating Env conformational changes, including shedding of gp120 from the Env trimer. By inducing more “open,” antibody-susceptible Env conformations, CD4mcs also sensitize HIV-1 virions to neutralization by antibodies and infected cells to antibody-dependent cellular cytotoxicity (ADCC). Here, we report the design, synthesis, and evaluation of novel CD4mcs based on an indoline scaffold. Compared with our current lead indane scaffold CD4mc, BNM-III-170, several indoline CD4mcs exhibit increased potency and breadth against HIV-1 variants from different geographic clades. Viruses that were selected for resistance to the lead indane CD4mc, BNM-III-170, are susceptible to inhibition by the indoline CD4mcs. The indoline CD4mcs also potently sensitize HIV-1-infected cells to ADCC mediated by plasma from HIV-1-infected individuals. Crystal structures indicate that the indoline CD4mcs gain potency compared to the indane CD4mcs through more favorable π–π overlap from the indoline pose and by making favorable contacts with the vestibule of the CD4-binding pocket on gp120. The rational design of indoline CD4mcs thus holds promise for further improvements in antiviral activity, potentially contributing to efforts to treat and prevent HIV-1 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV SeropositivityHIV InfectionsHumansAntibody-Dependent Cell CytotoxicityHIV Envelope Protein gp120CD4 AntigensHIV AntibodiesGuanidinesIndenesIndoles

Stichwörter der Autor:innen

antibody-dependent cellular cytotoxicityantiretroviral therapyentry inhibitorgp120structure-based drug design

Substanzen

HIV Envelope Protein gp120CD4 AntigensHIV AntibodiesBNM-III-170GuanidinesIndenesindolineIndoles

Autor:innen und Institutionen

  • Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104.
  • Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
  • Department of Microbiology, Harvard Medical School, Boston, MA 02115.
  • Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032.
  • Department of Chemical and Biological Engineering, Drexel University, Philadelphia, PA 19104.
  • Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.

ORCID-Profile: Zhen Gong, Mohammadjavad Mohammadi, Michael S Seaman, Wayne A Hendrickson

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • Canada Research Chairs

Zitieren

APA

Fritschi, C. J., Anang, S., Gong, Z., Mohammadi, M., Richard, J., Bourassa, C., Severino, K. T., Richter, H., Yang, D., Chen, H. C., Chiu, T. J., Seaman, M. S., Madani, N., Abrams, C., Finzi, A., Hendrickson, W. A., Sodroski, J. G., & Smith, A. B. (2023). Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2222073120

Vancouver

Fritschi CJ, Anang S, Gong Z, Mohammadi M, Richard J, Bourassa C, et al. Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2222073120

BibTeX
@article{Fritschi2023,
  author = {Fritschi, Christopher J and Anang, Saumya and Gong, Zhen and Mohammadi, Mohammadjavad and Richard, Jonathan and Bourassa, Catherine and Severino, Kenny T and Richter, Hannah and Yang, Derek and Chen, Hung-Ching and Chiu, Ta-Jung and Seaman, Michael S and Madani, Navid and Abrams, Cameron and Finzi, Andrés and Hendrickson, Wayne A and Sodroski, Joseph G and Smith, Amos B},
  title = {Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2222073120}
}
Kostenlos starten →